Information about BMS Pharmaceuticals Korea Holdings
My details
*
*
*

BMS Pharmaceuticals Korea Holdings (SRL)

Company information

Status
Active

KVK number

33030291

VAT Number

Established
01-05-1927
Last balance sheet year
2023
Company size
Big 0 FTE
RSIN number
001455072
Principal activity
Activiteiten van financiële holdings
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from BMS Pharmaceuticals Korea Holdings

2023 2022 2021 2020
Equity 50.591.000 0 % 50.400.000 0 % 50.426.000 0 % 50.446.000
Employees 0 0 0 0

Frequently asked questions

What is the KVK number of BMS Pharmaceuticals Korea Holdings?
The KVK number of BMS Pharmaceuticals Korea Holdings is 33030291
What is the VAT number of BMS Pharmaceuticals Korea Holdings?
Log in or start a free trial to view the VAT number.
Wat is the PEPPOL ID of BMS Pharmaceuticals Korea Holdings?
There is no information available about the PEPPOL ID of BMS Pharmaceuticals Korea Holdings or the company is not yet registered on the PEPPOL network.
When was BMS Pharmaceuticals Korea Holdings founded?
BMS Pharmaceuticals Korea Holdings was founded on 01-05-1927.
What is the address of BMS Pharmaceuticals Korea Holdings?
The current registered office of BMS Pharmaceuticals Korea Holdings is located at Orteliuslaan 1000, 3528 BD Utrecht.
When was the last time BMS Pharmaceuticals Korea Holdings filed their annual financial statements?
The most recent financial statements of BMS Pharmaceuticals Korea Holdings were filed on 31-12-2023.
How many employees does BMS Pharmaceuticals Korea Holdings have?
There are currently no employees working at BMS Pharmaceuticals Korea Holdings or no workforce information is available.
What is the annual turnover of BMS Pharmaceuticals Korea Holdings?
There is no turnover available for BMS Pharmaceuticals Korea Holdings.